Skip to content
OpenCapital
Get started

ICU Medical ICUI Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net

Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net at other companies

ITG
Integer HoldingsITGR
——
Fortive logo
FortiveFTV
——

Other financials

Income statement

See full
Revenue$530.2M-12.3%
Gross profit$206.2M-1.8%
Operating income$13.6M+5.4%
Net income$30.1M+295%
EPS (diluted)$1.20+290%

Balance sheet

See full
Cash & equivalents$288.3M-0.5%
Total debt$1.4B-17.5%
Total equity$2.1B+6.3%
Total assets$4.0B-4.1%

Cash flow

See full
Operating cash flow$38.9M-24.2%
CapEx$11.3M-22.7%
Free cash flow$27.6M-24.8%

Valuation

See full
Market cap$3.39B-6.3%

Profitability

See full
Gross margin37.9%+2.8pp
Operating margin2%-0.7pp
Net margin-0.3%-0.2pp
FCF margin4.2%-1.2pp

Returns & leverage

See full
Return on equity-0.4%-0.2pp
Debt / equity0.6×-0.2×
Current ratio2.3×-0.3×

Where this comes from

Reported directly by ICU Medical in its filing.

Tagged under the XBRL concept us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet.

The official record: ICU Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ICU Medical's debt instrument, unamortized discount (premium) and debt issuance costs, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ICU Medical's debt instrument, unamortized discount (premium) and debt issuance costs, net?
ICU Medical (ICUI) reported debt instrument, unamortized discount (premium) and debt issuance costs, net of -$9.24M in Q1 2026.
How has ICU Medical's debt instrument, unamortized discount (premium) and debt issuance costs, net changed year-over-year?
ICU Medical's debt instrument, unamortized discount (premium) and debt issuance costs, net increased by 27.9% year-over-year, from -$12.81M to -$9.24M.
What is the long-term trend for ICU Medical's debt instrument, unamortized discount (premium) and debt issuance costs, net?
Over 3 years (2022 to 2025), ICU Medical's debt instrument, unamortized discount (premium) and debt issuance costs, net has grown at a -26.0% compound annual growth rate (CAGR), from -$24.26M to -$9.83M.